Author:
Chen Wei,Liu Hu,Hou Shu-Ling,Li Xi,Li Li,Lian Ke,Wu Xiao-Bo,Zhang Xiao
Reference18 articles.
1. Drug-resistance mechanism and new targeted drugs and treatments of relapse and refractory DLBCL;Zhang;Cancer Manag Res,2023
2. CNS prophylaxis in aggressive B-cell lymphoma;Wilson;Hematol. Am. Soc. Hematol. Educ. Program,2022
3. National Comprehensive Cancer Network. B-cell lymphomas Version2[DB/OL]. Accessed 15 February 2021.
4. Clinical significance of β_2-microglobulin in serum and cerebrospinal fluid of patients with intracranial tumor;Lin;Xian Dai Yi Yuan,2014
5. Clinical significance of high β2 microglobulin in diffuse largeB-cell lymphoma;Yu;Beng Bu Yi Xue Yuan Xue Bao,2020